Epstein-Barr virus and oncogenesis: from latent genes to tumours. - Wikidata - awgldk - TriplyDB

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

http://www.wikidata.org/entity/Q34221194

about

FAT10 plays a role in the regulation of chromosomal stability Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis The Role of Gammaherpesviruses in Cancer Pathogenesis Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based meta-analysis Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus Enhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2 Interference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma Herpesviruses Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes Telomeres and telomere dynamics: relevance to cancers of the GI tract Early events associated with infection of Epstein-Barr virus infection of primary B-cells Polymicrobial infection and bacterium-mediated epigenetic modification of DNA tumor viruses contribute to pathogenesis Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation The A2 gene of alcelaphine herpesvirus-1 is a transcriptional regulator affecting cytotoxicity in virus-infected T cells but is not required for malignant catarrhal fever induction in rabbits Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo Comparison of commercial and in-house Real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in plasma.Treating cancer as an infectious disease--viral antigens as novel targets for treatment and potential prevention of tumors of viral etiology Role of the ubiquitin system and tumor viruses in AIDS-related cancer.The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types Dynamic distribution and expression in vivo of the human interferon gamma gene delivered by adenoviral vector.Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line.Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40.Comparison of commercial real-time PCR assays for quantification of Epstein-Barr virus DNA.Methylation of histone H3 and H4 by PRMT5 regulates ribosomal RNA gene transcription.Immunotherapy: opportunities, risks and future perspectives The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome Epstein-Barr Viral Load is Associated to Response in AIDS-Related Lymphomas.Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol)EBV, HCMV, HHV6, and HHV7 screening in bone marrow samples from children with acute lymphoblastic leukemia.Human viruses and cancer.Comparing proteomics and RISC immunoprecipitations to identify targets of Epstein-Barr viral miRNAs.Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infection

P2860

Q24305422-750FB73C-1B62-47EE-BEC7-AD3AAB960381 Q24657973-3B5934C8-BA21-4045-9D90-EA7F09C61DF9 Q26765643-4998D030-3B55-4AE5-BD6C-B6947E7D40FE Q26767186-6B8028E9-9039-407A-BC60-1F4FF0A2468C Q26775442-3FF5CB9D-0756-4428-AB42-A5C61236AF0A Q26786050-CB6FD152-128D-45B6-9D55-EFC83E3DC9F4 Q26852071-10D96F0B-C2F4-4360-97F5-DB58577163C3 Q27318672-3F844314-D430-4698-88A1-FC11F8307B1F Q28080898-9CC7242A-F444-4D82-9F86-F2EED74F0A70 Q28271456-E06A1C2F-6461-4B9C-AF93-7DA695302DD8 Q28394311-235DBA7D-B5B2-4F7E-BB08-28EB3B056D92 Q28476230-B83FAD5D-EE3C-4D4E-A5FC-58AA2C7C4371 Q28657924-89A09FD2-E4CB-48E7-A5B2-B6F3989F3BAF Q28731826-EBAB59BA-29D3-4322-81A4-DE7E16BFEC7C Q30394015-54A50539-FCC2-4D60-BA57-6C5A9F9927AC Q31090571-C7980C2F-0280-4AC9-BF8E-1FE449F43C9C Q33280299-9ED102B8-5413-4987-9AA5-D882B3BE4909 Q33304454-DE2E0CBE-936A-427F-8786-AD76394F20B2 Q33307881-6AA3EA50-4F00-4BED-BD47-B18B2EF80306 Q33389641-F3F461E3-042B-4DB4-B984-69ADB2D3C577 Q33409158-2913BBF4-2DCD-4792-B02B-9CA461E070C7 Q33598586-27EE293D-3F32-4495-954E-DB5C9AEDFDEA Q33638951-8BB398F4-C5D5-46B2-A7F9-0E1024702B87 Q33673610-04922053-088C-4168-8BFF-7BA043780ED8 Q33749934-74B1EF13-AF15-433F-B7C2-9EABC23700F9 Q33818584-6BD2EED7-D6D8-44FD-ABFF-9CD5ED787FFE Q33834753-C65A13DC-EF42-4796-9014-64BFDD69534F Q33859109-F6006288-443A-4193-A39B-82C3F503F4F0 Q33900206-D18B44C8-6F56-4E2E-9F72-B1FC6D0D6F99 Q33941012-634F1ABE-4BC4-49E3-8741-0E00F17E2751 Q33958500-787A8F70-91FD-4046-BECD-72E381D1A760 Q33969513-603F55C8-4E2E-47DC-8EB2-96B8AA3824CA Q34013830-59E15FC2-663D-4365-BEC8-8DD4FB30BF64 Q34212911-1E34E409-51F0-4918-A6A3-12ABD3B36CC8 Q34301695-1C0D68BE-31E3-4F03-BAD5-01A00407F557 Q34306768-0E6E92B9-FC8D-4015-B6B5-37E8D8B02120 Q34423461-D9078047-BFD9-4562-84E3-94C3CB66BEEA Q34455233-4CAA1F0A-6909-440D-8CEC-4D03CF82D890 Q34493991-0FF6FB8B-A7BC-4F2E-AB5C-041692CF52E2 Q34545445-BE080520-2C9B-4CCE-ACFB-50BADAC1110F

P2860

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

http://www.wikidata.org/entity/Q34221194

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

@ast

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

@en

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

@nl

type

label

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

@ast

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

@en

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

@nl

prefLabel

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

@ast

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

@en

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

@nl

P1433

Q34221194-46C7636F-EA0B-45B0-9303-CF30668D63FB

P1476

Q34221194-8B0C3B64-3CCB-477C-B02B-A82E41DE6AA7

P2093

Q34221194-99AA6BC9-7A42-4C65-99C8-C77CD77816E9

Q34221194-E868364D-B96C-42BB-AC32-707F0B15D9C5

P2860

Q34221194-04531BA2-1A5A-4B18-A4DD-695D1EB1625C

Q34221194-07A31E8A-6642-44DC-8C5D-A936B065D37F

Q34221194-091612C6-8F7A-43E1-AE70-85FC814598F2

Q34221194-12B43B68-788A-41B7-83A3-511A30829EBA

Q34221194-1BD5F11B-8D7C-4C7E-83FB-E6A60EC25A6B

Q34221194-1C1FEF11-B52B-47DD-863B-1D043BEBD72E

Q34221194-1CBDDFCC-6094-475A-B802-E2D99E281D43

Q34221194-1DDCCBEA-9EEC-4EE6-A123-6B3A4A688A69

Q34221194-23FB5FC4-8857-403B-A2C0-B7143E39B40C

Q34221194-267B40A1-58F6-4CDB-A137-E46A5195B077

P2888

Q34221194-697F398B-1B15-42D1-9B71-970FD3BAD196

P304

Q34221194-82505430-5D23-428F-8D64-F40BA0ECE249

P31

Q34221194-28C45DDB-E677-4C26-81CE-6E73719FA6E6

P356

Q34221194-7C3EF703-B687-4DA9-9A68-C74D8302CA5B

P407

Q34221194-226E91A2-3A97-4C69-BE4D-EEF19F0D3988

P433

Q34221194-E5881D61-31A7-4BBC-A412-E2040E8E737D

P478

Q34221194-866F238F-6E27-4AD8-969E-91DB56D1E022

P577

Q34221194-9E5746B7-53B5-45DA-BAFE-300F8C4C1899

P5875

Q34221194-07D54172-30B5-425D-ABE8-9ED6202C5259

P6179

Q34221194-58DE1CE0-939F-48B0-A07A-4F9488DA69E3

P698

Q34221194-659E3BD8-C5E4-4AED-BBB7-9240E2A9371D

P921

Q34221194-74C3D62C-F66A-40CC-B403-38E4C2F73A7F

P356

P1433

P1476

Epstein-Barr virus and oncogenesis: from latent genes to tumours.

@en

P2093

Lawrence S Young

http://www.w3.org/2001/XMLSchema#string

Paul G Murray

http://www.w3.org/2001/XMLSchema#string

P2860

The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus

The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2

An Epstein-Barr-related herpesvirus from marmoset lymphomas.

The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.

Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas.

Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells

Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

P2888

P304

5108-5121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206556

http://www.w3.org/2001/XMLSchema#string

P407

P433

33

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10620526

http://www.w3.org/2001/XMLSchema#string

P6179

1025864988

http://www.w3.org/2001/XMLSchema#string

P698

12910248

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus